Document is current

Any future updates will be listed below

Correction: YC-1 enhances the anti-tumor activity of sorafenib through inhibition of signal transducer and activator of transcription 3 (STAT3) in hepatocellular carcinoma

Crossref DOI link: https://doi.org/10.1186/s12943-025-02565-7

Published Online: 2026-01-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark